Right time. Right place. Right concentration.

Loading Events

« All Events

  • This event has passed.

6th Annual Course on the BBB in Drug Development 2015 (Uppsala, Sweden)

October 7, 2015 - October 9, 2015


General


Following the previously successful ones, the 6th Annual Course on the BBB in CNS Drug Development is organized in 2015!

Aim

This course addresses the latest insights on role and functions of the Blood-Brain Barrier (BBB) and intra-brain distribution in research concerning drug development regarding drugs aimed for a target within the CNS or drugs aimed to stay outside of the CNS, and will address also CNS drug delivery and CNS diseases. It provides in depth insight in the complex function of the BBB with regard to transport kinetics in health and disease.

Background

There is a high unmet medical need in the treatment of CNS diseases and this problem is getting worse as the number of people suffering from CNS diseases is growing. This implies that there is a huge market for new CNS drugs. However, the development of new CNS drugs is notoriously difficult. For a proper CNS effect the drug should have the ability to cross the BBB and then to reach the relevant target site within the CNS by adequate intra-brain distribution. Also drugs that are aimed to have a peripheral action, but may bear risks for CNS side effects can be better optimized with more knowledge on BBB transport and CNS side effect site distribution.

Thus, knowledge on the physiological and pharmacokinetic aspects of drug delivery to the brain and distribution within the brain compartments is of utmost importance for all drug delivery scientists. Also medicinal chemists need further knowledge on pharmacokinetic principles of CNS distribution to be guided in finding more optimal molecules for CNS action or for the avoidance of CNS side effects.

Who should attend?

This course will be of benefit to researchers from Academia, Big and Small Pharma Industries, Regulatory Agencies and Contract Research Organizations with a need for better understanding of the BBB and factors that determine CNS target site distribution of drugs. A general understanding of physiology and minimal knowledge of differential equations is expected (some information can be provided upon request).

Learning Objectives

After having taken this course, the participants will

  • have in-depth insight into mechanisms that contribute to BBB transport and intra-brain distribution, with special emphasis on drug delivery and active transport mechanisms
  • know about the driving forces that determine whether or not a CNS drug will be at the right place, at the right time and at the right concentration
  • be able to compare and choose between different methods for studying parameters that can be used to understand or even predict BBB transport and CNS distribution


Program


Wednesday Oct 7th 2015

Basic Aspects of the Blood-Brain Barrier and Pharmacokinetic Principles

09.00 – 09.30 Welcome and Introduction
09.30 – 10.00 BBB Morphology, Anatomy, Physiology and Function
10.00 – 10.30 Coffee and Tea
10.30 – 11.30 BBB Transport Modes
11.30 – 12.30 General Pharmacokinetic (PK) Principles
12.30 – 14.00 Lunch
14.00 – 14.45 Approaches to Overcome Problems in CNS Drug Delivery
14.45 – 15.30 Factors in CNS Drug Effects
15.30 – 16.00 Coffee and Tea
16.00 – 16.45 Sources of variability in CNS Drug Distribution
16.45 – 17.30 Discussions BBB Research Issues
18.00 – 20.00 Dinner

Thursday Oct 8th 2015

Principles and Methods for Investigating BBB Transport 

09.00 – 10.00 BBB transport: Rate and Extent. Impact on Brain vs Plasma PK
10.00 – 10.30 Coffee and Tea
10.30 – 11.00 In vitro Methods: Cell systems
11.00 – 11.30 In Situ Methods
11.30 – 12.30 In vitro Methods: Brain slice and Homogenate
12.30 – 13.30 Lunch
13.30 – 14.30 In vivo Monitoring Methods: CSF & Microdialysis
14.30 – 15.30 In vivo Monitoring Methods: PET
15.30 – 16.00 Coffee and tea
16.00 – 17.00 Factors that influence unbound brain pharmacokinetics
17.00 – 17.30 Discussions
18.00 – 21.30 Dinner

Friday Oct 9th 2015

Pharmacokinetics of CNS Drug Delivery

09.00 – 10.00 PKPD relationships of CNS active drugs
10.00 – 10.30 Coffee and Tea
10.30 – 11.00 PKPD relationships of CNS active drugs (cont.)
11.00 – 12.30 Hands-on comp Exercises on Relationships between Plasma and Brain PK
12.30 – 13.30 Lunch
13.30 – 14.30 What Parameters to Use in CNS Drug Development?
14.30 – 15.00 Discussion, Perspectives, and Conclusions
15.00 – 15.15 Course Evaluation, Certificates and final comments

Evaluations from the 2014 course in Leiden
On a scale from 1 – 10, where 10 is top evaluation, the course received the following scores in 2014:

“I found the course to be very valuable for my present work”: 9.0
“I would very much like to recommend this course to colleagues”: 9.3


Location



Uppsala Konsert & Kongress
Vaksala torg 1, 753 31 Uppsala, Sweden
http://www.ukk.se/In-English/

sweden


Map


Registration



Fee

The course fee includes course attendance, course material, lunches, dinners, coffee/tea at start and during breaks. It does not include accommodation.

Payment completed before September 1st 2015:

PhD students* € 1495,- (excl. VAT)
Academic € 1695,- (excl. VAT)
Business € 1895,- (excl. VAT)

Payment completed before October 1st 2015:

PhD students* € 1695,- (excl. VAT)
Academic € 1895,- (excl. VAT)
Business € 2095,- (excl. VAT)

For participants based in Sweden, please add VAT 25 %

*PhD students should accompany this form by a letter of their supervisor to ensure the status of PhD student.

Registration Form

Please register by sending an email to info@bbbcourses.org or filling out the form below. A specified invoice can be made upon request. Registration is complete upon receiving the payment. A confirmation will be sent by email.

Name participant:

Job title:

Email address:

Affiliation:

Date:

Fee includes course attendance, course material, lunches, dinners, coffee/tea at start and during breaks. It does not include accommodation. Please tick the appropriate:

Payment completed before September 1st 2015 :
PhD students: € 1495,-Academic: € 1695,-Business: € 1895,-

Payment completed before October 1st 2015 :
PhD students: € 1695,-Academic: € 1895,-Business: € 2095,-

PhD students should accompany a letter from their supervisor to ensure the status of PhD student:

Payment information
Udenaes Consulting
SEB Bank
bg 459–9361 (if payment from Sweden)
IBAN Account: SE3850000000053681044384
BIC: ESSESESS
Skandinaviska Enskilda Banken, 106 40 Stockholm, Sweden
Via PayPal at udenaesconsulting@gmail.com
For payment with credit card via PayPal, please add 3.4 %

Company Information
Udenaes Consulting
Bruksvägen 29
752 41 Uppsala, Sweden
+46 (0) 70 – 5301 147
udenaesconsulting@gmail.com
VAT: SE530124754901

Cancellation policy

In case of cancellation before Aug 1st 2015 payment will be restituted (-10% administration costs). In case of cancellation after Aug 1st 2015 there will be no restitution, but the participant may be exchanged for another participant.

Team



The course is a coproduction of In Focus and Udenaes Consulting:

Elizabeth de Lange

Elizabeth de Lange

2013Margareta

Margareta Hammarlund-Udenaes

 

 

 

 

 

 

 

Elizabeth de Lange is Head of the Target Site Equilibration group of the Division of Pharmacology at the LACDR. She obtained her PhD on The Use of Microdialysis to Study the BBB Transport Characteristics of Drugs. Her ultimate aim is to aid in the prediction of the dose-response relationship of CNS drugs in the clinical setting, on the basis of preclinical data (translational research). Her research involves the identification and characterization of the rate and extent of key factors in the dose-response relationship of CNS drugs in health and CNS disorders. Dr de Lange’s current research involves the use of advanced preclinical research (e.g. including microdialysis, EEG monitoring, PET scanning) and advanced pharmacometrics (Systems Pharmacology).

Dr Ede Lange is a member of the Editorial Board of Fluids and Barriers of the Central Nervous System (FBCNS) . She co-founded and (co-) chaired several of the International Symposia on Microdialysis in Drug R&D. She has been Chair of the Organizing Committee of the 9th International Cerebrovascular Biology (CVB), Conference (2011, Leiden, The Netherlands). Furthermore, she was the 2014 Chair of the Annual Meeting Programming Committee of the American Association of Pharmaceutical Scientists (AAPS), after many other functions within this organization. She is an AAPS Fellow since 2013. She is a frequently invited lecturer. Her company In Focus provides courses, training and advice on microdialysis, pharmacokinetics, BBB transport, and CNS target site distribution and effects, and systems pharmacology.
(info@infocus-ecmdelange.nl).

Margareta Hammarlund-Udenaes is a Professor in Pharmacokinetics and Pharmacodynamics at Uppsala University and head of the Translational PKPD Group. Her research is focused at studying pharmacokinetic aspects of BBB transport of drugs in relation to CNS effects, which has led to the development of new concepts within the BBB transport area, focusing on unbound drug relationships. The concepts make it possible to study the BBB contribution to drug transport to the CNS. A method frequently used is microdialysis, but also PET and other techniques are utilized. Her research group has also optimized in vitro methods for more rapid screening of BBB transport properties in drug discovery.

Dr Hammarlund-Udenaes is an Associate Editor of Pharmaceutical Research and a member of the Editorial Advisory Board of Journal of Pharmaceutical Sciences and Fluids and Barriers of the Central Nervous System (FBCNS). She became an AAPS Fellow in 2005 and is a frequent lecturer at conferences and in drug industry within the BBB transport – pharmacokinetics area. She co-founded and has co-chaired several of the International Symposia on Microdialysis in Drug Research and Development together with Dr de Lange. She is the Chair of the Gordon Conference on Barriers of the CNS in 2014. Her company Udenaes Consulting (udenaesconsulting@gmail.com) gives advice to drug industry in PKPD and BBB transport issues.


Hotels



Hotels


hotelradRadisson Blu, Uppsala

Stationsgatan 4
753 40 Uppsala

3 min walk from the course site and 1 min walk from the train stn.
Radisson Blu is a new, very modern, high-level hotel in Uppsala, located in the very centre of the city.

hotelrad2Free internet. The hotel is easily accessible from Stockholm International Airport with only 30 min by taxi or train, or 50 min with bus, and from Stockholm or other parts of Sweden by air or train. Reservations made and paid 21 days before the arrival will have a lower cost.
http://www.radissonblu.com/hotel-uppsala

Other recommended hotels

hotelse1Park Inn by Radisson Uppsala, Storgatan 30, Uppsala. This 4-star hotel is 2 min walk from the course site and 3 min walk from the train station. Reservations made and paid 21 days before the arrival will have a lower cost. http://www.parkinn.com/hotel-uppsala

hotelse2Best Western Hotel Svava, Bangårdsgatan 24, Uppsala. This hotel is located on the other side of the train station with a walk of 5 minutes to the course site. http://www.hotelsvava.se/

hotelse3Hotell & Hostel Centralstation is a hostel and low-cost hotel at Bangårdsgatan 13, opposite to the Best Western Hotel Svava. It is also located only 5 min from the course site. http://www.hotellcentralstation.se/

More hotels can be found on hotels.combooking.com or expedia.se where reservations also can be made.


 

<< previous events

Details

Start:
October 7, 2015
End:
October 9, 2015

Venue

Uppsala Konsert & Kongress
Vaksala torg 1
Uppsala, 753 31 Sweden

Organizer

Udenaes Consulting